10:05:15 EDT Thu 18 Apr 2024
Enter Symbol
or Name
USA
CA



Emerald Health Therapeutics Inc
Symbol EMH
Shares Issued 106,723,449
Close 2018-01-05 C$ 7.22
Market Cap C$ 770,543,302
Recent Sedar Documents

Emerald Health appoints Dillman VP, sales and marketing

2018-01-08 08:02 ET - News Release

Mr. Chris Wagner reports

EMERALD HEALTH THERAPEUTICS APPOINTS PAUL R. DILLMAN, JR. TO VICE PRESIDENT OF SALES AND MARKETING

Emerald Health Therapeutics Inc. has appointed Paul R. Dillman Jr. as the company's vice-president of sales and marketing. Mr. Dillman will be responsible for marketing, sales and customer service, and will lead Emerald's brand strategy and execution as the company prepares for anticipated legalization of adult-use cannabis in Canada by July, 2018.

"Paul has been instrumental in preparing for and executing sales growth as a senior leader at some of the world's most successful fast-moving consumer packaged goods companies. His strategic and tactical marketing expertise will be invaluable as we position Emerald for leadership in the Canadian and global cannabis industry," said Chris Wagner, chief executive officer of Emerald.

Mr. Dillman brings three decades of experience in global marketing, sales and general management to Emerald, and has held senior leadership positions at The Coca-Cola Company, AB InBev, Philip Morris and Kraft Foods.

Mr. Dillman earned a bachelor of science from West Point (United States Military Academy) and a master of science in systems management from the University of Southern California.

"I'm thrilled to join the dynamic organization that Emerald is building," said Mr. Dillman. "With its current expansion projects and product innovation plans, Emerald is poised to be a premiere provider of cannabis for medical and adult-use consumers. I look forward to planning and executing a marketing and sales strategy that will contribute to this goal."

Mr. Dillman has been granted an option to acquire up to 150,000 common shares vesting over three years.

About Emerald Health Therapeutics Inc.

Emerald Health Therapeutics operates through Emerald Health Botanicals Inc., a wholly owned subsidiary and licensed producer under Canada's Access to Cannabis for Medical Purposes Regulations. Through Botanicals, Emerald is authorized to produce and sell dried medical cannabis flower and medical cannabis oil. It currently operates an indoor facility in Victoria, B.C., and is building a 500,000-square-foot greenhouse on 32 acres in metro Vancouver, with expansion potential to one million square feet to serve the anticipated legal Canadian adult-use cannabis market starting in 2018. Emerald also owns 50 per cent of Pure Sunfarms, a partnership with Village Farms that is converting an existing 1.1-million-square-foot greenhouse in Delta, B.C., from growing tomatoes to growing cannabis.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.